Lidia Mak

Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models

Alberto Gabizón, Dinah Tzemach, Lidia Mak et al. · Journal of drug targeting · 2002 · 155 citations

Immunology, Pharmacotherapy, Metronomic Chemotherapy +17

Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors

Hilary Shmeeda, Lidia Mak, Dina Tzemach et al. · Molecular Cancer Therapeutics · 2006 · 138 citations

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models

Alberto Gabizón, Dina Tzemach, Jenny Gorin et al. · Cancer Chemotherapy and Pharmacology · 2009 · 116 citations

Drug Targeting, Medicine, Pharmacology +9

Her2-targeted pegylated liposomal doxorubicin: Retention of target-specific binding and cytotoxicity after in vivo passage

Hilary Shmeeda, Dina Tzemach, Lidia Mak et al. · Journal of Controlled Release · 2009 · 96 citations

Drug Targeting, Vivo Passage, Target-specific Binding +8

Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells

Hilary Shmeeda, Yasmine Amitay, Jenny Gorin et al. · Journal of Controlled Release · 2010 · 94 citations

Cell-based Drug Delivery, Nanomedicine, Zoledronic Acid +12